|
|
 | | | |
- close
- close
- close
- close
Cross Timbers Royalty Trust (CRT) |
The Straits Times
May 10
Comment
May 11, 2013 12:51 AM
UNITS of Japan-focused Croesus Retail Trust (CRT) debuted strongly on the Singapore bourse yesterday.
Cloud Computing
May 7
Comment
NEW YORK
,
May 7, 2013
/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015
read more
Benzinga
Apr 30
Comment
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today
announced CE Mark approval and European launch of its Allure Quadra^™ Cardiac
Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more
pacing options to...
Forbes
Apr 25
Comment
Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive results of the smaller trial seem likely to...
Forbes
Apr 24
Comment
Patients with atrioventricular (AV) block generally receive right ventricular pacing; cardiac resynchronization therapy (CRT) has been restricted to patients with a low ejection fraction and a wide QRS duration. However, RV pacing may worsen LV...
MedPage Today
Jan 28
Comment
SAN FRANCISCO (MedPage Today) -- When paired with chemoradiotherapy, capecitabine offered better survival and toxicity outcomes than gemcitabine in locally advanced pancreatic cancer, researchers reported here.
Forbes
Jan 25
Comment
Looking at the universe of stocks we cover at Dividend Channel, on 1/29/13, Cross Timbers Royalty Trust (NYSE: CRT) will trade ex-dividend, for its monthly dividend of $0.1578, payable on 2/14/13. As a percentage of CRT's recent stock price of...
MedPage Today
Jan 25
Comment
(MedPage Today) -- Some patients have a cardiomyopathy induced by left bundle branch block in the absence of structural heart disease that can be resolved with cardiac resynchronization therapy, a retrospective study suggested.
Benzinga
Jan 17
Comment
Astex Pharmaceuticals (NASDAQ: ASTX) today announced that collaborators Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
